Journal article · 2015 · Open access

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications

Behnam Ahmadian Baghbaderani, Xinghui Tian, Boon Hwa Neo, Amy Burkall, Tracy Dimezzo, Guadalupe Sierra, Xianmin Zeng, Kim Warren, Don Paul Kovarcik, Thomas Fellner, Mahendra S. Rao

Stem Cell Reports, 5(4), 647–659 · Published 24 September 2015 · DOI 10.1016/j.stemcr.2015.08.015

Open PDFView at the publisherCite this paper

In brief

“cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications” is a 2015 journal article by Behnam Ahmadian Baghbaderani and 10 co-authors, published in Stem Cell Reports. OpenAlex counts 227 citations as of 21 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Stem Cell Reports.

Citations
227
Most cited in
2024 (27)
Field-weighted impact
4.97
References
33
Authors
11

Abstract

The discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of protocols for their cell-type-specific differentiation have revolutionized our approach to cell therapy. It has now become critical to address the challenges related to the generation of iPSCs under current good manufacturing practice (cGMP) compliant conditions, including tissue sourcing, manufacturing, testing, and storage. Furthermore, regarding the technical challenges, it is very important to keep the costs of manufacturing and testing reasonable and solve logistic hurdles that permit the global distribution of these products. Here we describe our efforts to develop a process for the manufacturing of iPSC master cell banks (MCBs) under cGMPs and announce the availability of such banks.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Baghbaderani, B. A., Tian, X., Neo, B. H., Burkall, A., Dimezzo, T., Sierra, G., Zeng, X., Warren, K., Kovarcik, D. P., Fellner, T., & Rao, M. S. (2015). cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications. Stem Cell Reports, 5(4), 647–659. https://doi.org/10.1016/j.stemcr.2015.08.015

MLA 9

Baghbaderani, Behnam Ahmadian, et al. “cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.” Stem Cell Reports, vol. 5, no. 4, 2015, pp. 647–659. https://doi.org/10.1016/j.stemcr.2015.08.015.

Chicago

Baghbaderani, Behnam Ahmadian, Xinghui Tian, Boon Hwa Neo, Amy Burkall, Tracy Dimezzo, Guadalupe Sierra, Xianmin Zeng, et al. 2015. “cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.” Stem Cell Reports 5 (4): 647–659. https://doi.org/10.1016/j.stemcr.2015.08.015.

Harvard

Baghbaderani, B. A. et al. (2015) ‘cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications’, Stem Cell Reports, 5(4), pp. 647–659. doi:10.1016/j.stemcr.2015.08.015.

IEEE

B. A. Baghbaderani et al., “cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications,” Stem Cell Reports, vol. 5, no. 4, pp. 647–659, 2015, doi: 10.1016/j.stemcr.2015.08.015.

BibTeX

@article{baghbaderani2015cgmp,
  title     = {{cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications}},
  author    = {Baghbaderani, Behnam Ahmadian and Tian, Xinghui and Neo, Boon Hwa and Burkall, Amy and Dimezzo, Tracy and Sierra, Guadalupe and Zeng, Xianmin and Warren, Kim and Kovarcik, Don Paul and Fellner, Thomas and Rao, Mahendra S.},
  journal   = {Stem Cell Reports},
  year      = {2015},
  volume    = {5},
  number    = {4},
  pages     = {647--659},
  doi       = {10.1016/j.stemcr.2015.08.015},
  url       = {https://doi.org/10.1016/j.stemcr.2015.08.015}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20171919
20181717
20192020
20202222
20212121
20222222
20232020
20242727
20252424
20261818

Its field-weighted citation impact is 4.97: it has been cited 4.97 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • cGMP production
  • master cell bank
  • cell therapy
  • cell banking
  • production costs

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Baghbaderani, B. A., Tian, X., Neo, B. H., Burkall, A., Dimezzo, T., Sierra, G., Zeng, X., Warren, K., Kovarcik, D. P., Fellner, T., & Rao, M. S. (2015). cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications. Stem Cell Reports, 5(4), 647–659. https://doi.org/10.1016/j.stemcr.2015.08.015

How many times has this paper been cited?

227 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Stem Cell Reports: sign in and open the PDF from this page.

Who wrote this paper?

Behnam Ahmadian Baghbaderani, Xinghui Tian, Boon Hwa Neo, Amy Burkall, Tracy Dimezzo, Guadalupe Sierra, Xianmin Zeng, Kim Warren, Don Paul Kovarcik, Thomas Fellner, Mahendra S. Rao.

What is the DOI of this paper?

10.1016/j.stemcr.2015.08.015, permanently at https://doi.org/10.1016/j.stemcr.2015.08.015. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.